EI
ATRA icon

Ellevest Inc’s Atara Biotherapeutics ATRA Stock Holding History

Ellevest Inc’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$59 – 1889
2022
Q4 		$59 Buy
+1
New +$104 ﹤0.01% 1783
2022
Q2 		– Sell
-5
Closed -$1K – 1394
2022
Q1 		$1K Hold
5
– – ﹤0.01% 1257
2021
Q4 		$2K Hold
5
– – ﹤0.01% 1135
2021
Q3 		$2K Hold
5
– – ﹤0.01% 1104
2021
Q2 		$2K Hold
5
– – ﹤0.01% 1008
2021
Q1 		$2K Hold
5
– – ﹤0.01% 1034
2020
Q4 		$3K Hold
5
– – ﹤0.01% 896
2020
Q3 		$2K Buy
5
+2
+67% +$681 ﹤0.01% 881
2020
Q2 		$1K Sell
3
-1
-25% -$253 ﹤0.01% 951
2020
Q1 		$1K Buy
4
+2
+100% +$635 ﹤0.01% 839
2019
Q4 		$1K Buy
+2
New +$690 ﹤0.01% 733

Other funds holding ATRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Ellevest Inc's ATRA Position: Q1 2023 in Review

Ellevest Inc sold out of Atara Biotherapeutics (ATRA) in Q1 2023, closing a stake of 1 share — an estimated $59 sold.

Ellevest Inc first reported a position in ATRA in Q4 2019 and held it in 11 quarters. The position peaked at $3K in Q4 2020. 125 funds tracked by Wall St. Rank hold ATRA as of Q1 2023.

  • Ellevest Inc reported no remaining Atara Biotherapeutics position as of Q1 2023 after selling out during the quarter.
  • Ellevest Inc sold 1 Atara Biotherapeutics share in Q1 2023, an estimated $59.
  • Ellevest Inc first reported a position in Atara Biotherapeutics in Q4 2019 and held it in 11 quarters.
  • Ellevest Inc's Atara Biotherapeutics position peaked at $3K in Q4 2020.
  • 125 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2023.

Based on Ellevest Inc's 13F filing for Q1 2023, filed 4 May 2023.